DuoGenic StemCells (ROCO:7607) EPS (Basic) : NT$-2.02 (TTM As of Dec. 2024)

View and export this data going back to 2023. Start your Free Trial

What is DuoGenic StemCells EPS (Basic)?

DuoGenic StemCells's basic earnings per share (Basic EPS) for the six months ended in Dec. 2024 was NT$-0.96. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2024 was NT$-2.02.

DuoGenic StemCells's EPS (Diluted) for the six months ended in Dec. 2024 was NT$-0.96. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was NT$-2.02.

DuoGenic StemCells's EPS without NRI for the six months ended in Dec. 2024 was NT$-0.96. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2024 was -2.02.

During the past 3 years, the average EPS without NRI Growth Rate was -32.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 4 years, DuoGenic StemCells's highest 3-Year average EPS without NRI Growth Rate was -32.90% per year. The lowest was -32.90% per year. And the median was -32.90% per year.

DuoGenic StemCells EPS (Basic) Historical Data

The historical data trend for DuoGenic StemCells's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DuoGenic StemCells EPS (Basic) Chart

DuoGenic StemCells Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

EPS (Basic)

-0.86

-1.18

-1.50

-2.02

DuoGenic StemCells Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
EPS (Basic)	Get a 7-Day Free Trial			-0.66	-0.73	-0.77	-1.06	-0.96

DuoGenic StemCells EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

DuoGenic StemCells's Basic EPS for the fiscal year that ended in Dec. 2024 is calculated as

Basic EPS (A: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-61.578	-	0)	/	30.484
	=	-2.02

DuoGenic StemCells's Basic EPS for the quarter that ended in Dec. 2024 is calculated as

Basic EPS (Q: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-29.282	-	0)	/	30.415
	=	-0.96

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$-2.02

DuoGenic StemCells (ROCO:7607) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

DuoGenic StemCells EPS (Basic) Related Terms

Thank you for viewing the detailed overview of DuoGenic StemCells's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

DuoGenic StemCells Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DuoGenic StemCells Corp (ROCO:7607) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

Room R207, Innovation Incubation Center, 145, Xingda Road, South District, Taichung, TWN

Website

https://www.dgsc.com.tw

DuoGenic StemCells Corp is a company having a team of passionate researchers focused on stem cell cultivation. Their products are intended for research use and can be upgraded for clinical applications. It also develops blood cell therapy programs, using the isolation and purification of blood mononuclear cells to remove granule cells that promote inflammation, and conducts clinical trials on various degenerative diseases to provide a convenient and simple new option for cell therapy.

DuoGenic StemCells Headlines

No Headlines